Why scientists are alarmed

Researchers who spoke out described the dismissals as an unprecedented disruption to the normal process of distributing federal research funds. Their concern centers on what happens next: without an advisory board in place, decisions about billions of dollars in grants could be made without the usual independent scientific review.

Scientists have taken their case directly to Congress, arguing that lawmakers — who authorized the agency and its advisory structure in the first place — have both the authority and the responsibility to check the executive branch's actions.

The stakes

Federal science funding supports work at universities, national laboratories, and independent research institutions across the country. Grant decisions made today determine which medical studies, basic research projects, and technical programs move forward over the coming years.

A break in the advisory process carries practical consequences. Pending grant applications may face delays. Long-term research programs could lose their oversight. And early-career scientists, who often depend on timely funding decisions to launch their work, face particular uncertainty.

What comes next

The push for congressional action is still in its early stages, and it remains unclear how lawmakers will respond. Any resolution would likely require either legislation or sustained political pressure to restore the board or establish an alternative oversight mechanism.

Scientists involved in the effort say they will continue making their case to Congress in the coming weeks. The outcome could shape not just the future of this one agency, but the broader question of how much independence federal science agencies retain from presidential administrations.

This is a developing story. Details about the scope of the dismissals and the administration's justification may continue to emerge.